Science Explorer Back to mapMap
Discussion
Researcher · Nordic Bioscience (Denmark) · Denmark

Shu Sun

Shu Sun publishes mostly in Molecular Biology, Rheumatology and Cancer Research, on topics such as Protease and Inhibitor Mechanisms, Cell Adhesion Molecules Research and Coagulation, Bradykinin, Polyphosphates, and Angioedema.

ORCID 0000-0002-2477-8904 OpenAlex
World rank
#1,688,270
of 7,710,434 ranked researchers
Rank in Denmark
#12,778
of 43,819
Works
84
Citations
1.7k
Citations per work
19.7
h-index
20
i10-index 31Top 33% in Molecular Biology
Shu Sun

What does Shu Sun research?

Shu Sun's work is mostly in Medicine (27%), Biochemistry, Genetics and Molecular Biology (16%).

Everything else: 48 works · 57.6% of their workHealth Sciences: 22 works · 26.6% of their workMedicine: 22 works · 26.6% of their workRheumatology: 8 works · 9.0% of their workOncology: 5 works · 6.3% of their workHematology: 5 works · 5.9% of their workPulmonary and Respiratory Medicine: 5 works · 5.4% of their workLife Sciences: 13 works · 15.8% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 15.8% of their workMolecular Biology: 8 works · 9.0% of their workCancer Research: 6 works · 6.8% of their workTHEIR WORKShu Sun84works
Life Sciences16%Health Sciences27%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else4857.6%
    1. Medicine2226.6%
    1. Biochemistry, Genetics and Molecular Biology1315.8%
  1. 1Molecular Biology9% of their works
  2. 2Rheumatology9% of their works
  3. 3Cancer Research7% of their works
  4. 4Oncology6% of their works
  5. 5Hematology6% of their works
  6. 6Pulmonary and Respiratory Medicine5% of their works

Research topics

Which keywords describe Shu Sun's research?

The keywords of their largest research topics: Angiogenesis, Extracellular Matrix, Inflammation, Cell Adhesion, Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, Cancer and Integrins.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Angiogenesis242 topics
  2. Extracellular Matrix242 topics
  3. Inflammation172 topics
  4. Cell Adhesion162 topics
  5. Matrix Metalloproteinases131 topic
  6. Tissue Inhibitors of Metalloproteinases131 topic
  7. Cancer111 topic
  8. Integrins111 topic
  9. Biological Therapy61 topic
  10. Hereditary Angioedema61 topic
  11. Kinin Receptor Family61 topic
  12. Rheumatoid Arthritis61 topic
  13. Ankylosing Spondylitis51 topic
  14. Intermediate Filaments51 topic
  15. Keratins51 topic
  16. Spondyloarthritis51 topic
  17. Crohn's Disease41 topic
  18. Inflammatory Bowel Disease41 topic
  19. Muscle Regeneration41 topic
  20. Skeletal Muscle Atrophy41 topic

Where does Shu Sun work?

Shu Sun's main affiliation in the publication record is Nordic Bioscience (Denmark), Denmark.

How many publications and citations does Shu Sun have?

OpenAlex counts 84 works and 1,654 citations for Shu Sun, an h-index of 20, ranking #1,688,270 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Shu Sun

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Shu Sun. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.